Herantis Pharma to Participate in the Upcoming Swiss Nordic Bio Conference
Press Release Herantis Pharma Plc 8 February 2021 at 05:20 p.m. EET Herantis Pharma Plc (“Herantis”), an innovative clinical stage biotech company pioneering new disease modifying and regenerative biologic and gene therapies, today announced that Craig Cook, Chief Executive Officer, will hold a company presentation in the upcoming Swiss Nordic Bio Conference investor conference, this year taking place virtually. Event Details: Swiss Nordic Bio Conference 10 – 11 February 2021 On 11 February 2021 all presentations will be available via a digital library, which is